ArthroCare to Present During Piper Jaffray London Health Care Conference

ArthroCare(R) Corp. (Nasdaq:ARTC), a multi-businessmedical device company that develops minimally invasive surgicalproducts, announced today it will present during the Piper JaffrayLondon Health Care Conference. Fernando Sanchez, senior vice presidentof business development for ArthroCare, and Norman R. Sanders, M.D.,vice president and chief medical officer for the company, will deliverthe business presentation. Further details include:
-- Date: Fri., June 23, 2006

-- Time: 9:40 a.m. BST / 8:40 a.m. GMT / 4:40 a.m. EDT

-- Location: The Brewery at Chiswell Street / London EC1Y 4SD

The presentation will be Webcast live and can be accessed onArthroCare's Web site at www.arthrocare.com. The Web cast will remainavailable for 30 days following the presentation.

About ArthroCare

Founded in 1993, ArthroCare Corp. (www.arthrocare.com) is a highlyinnovative, multi-business medical device company that develops,manufactures and markets minimally invasive surgical products. Withthese products, ArthroCare targets a multi-billion Dollar marketopportunity across several medical specialties, significantlyimproving existing surgical procedures and enabling new, minimallyinvasive procedures. Many of ArthroCare's products are based on itspatented Coblation technology, which uses low-temperatureradiofrequency energy to gently and precisely dissolve rather thanburn soft tissue -- minimizing damage to healthy tissue. Used in morethan four million surgeries worldwide, Coblation-based devices havebeen developed and marketed for sports medicine; spine/neurologic;ear, nose and throat (ENT); cosmetic; urologic and gynecologicprocedures. ArthroCare also has added a number of novel technologiesto its portfolio, including Opus Medical sports medicine, Parallaxspine and Applied Therapeutics ENT products, to complement Coblationwithin key indications.

Safe Harbor Statements

Except for historical information, this press release includesforward-looking statements. These statements include, but are notlimited to, the company's stated business outlook for fiscal 2006,continued strength of the company's fundamental position, the strengthof the company's technology, the company's belief that strategic moveswill enhance achievement of the company's long term potential, thepotential and expected rate of growth of new businesses, continuedsuccess of product diversification efforts, and other statements thatinvolve risks and uncertainties. These risks and uncertaintiesinclude, but are not limited to the uncertainty of success of thecompany's non-arthroscopic products, competitive risk, uncertainty ofthe success of strategic business alliances, uncertainty overreimbursement, need for governmental clearances or approvals beforeselling products, the uncertainty of protecting the company's patentposition, and any changes in financial results from completion ofyear-end audit activities. These and other risks and uncertainties aredetailed from time to time in the company's Securities and ExchangeCommission filings, including ArthroCare's Form 10-Q for the quarterended March 31, 2006 and Form 10-K for the year ended Dec. 31, 2005.Forward-looking statements are indicated by words or phrases such as"anticipates," "estimates," "projects," "believes," "intends,""expects," and similar words and phrases. Actual results may differmaterially from management expectations.